Live
FierceBiotechBoehringer furthers inflammatory expansion with €407M biobucks bet on Immunitas assetEndpoints NewsBayer to make 'careful but aggressive' return to pharma M&A, CEO saysEndpoints NewsAlkermes' narcolepsy Phase 3 success; Boehringer's antibody dealFierceBiotechAstraZeneca’s $800M bet undermined by immunogenicity in phase 310x Genomics NewsA Look At 10x Genomics (TXG) Valuation After A Strong Year And Recent Share Price Pullback - Yahoo FinancePharmaVoiceHow tough is it getting for vaccine makers in the U.S.?FDA News ReleasesFDA Finalizes Food Chemical Safety Post-Market Assessment Program, Launches Reassessment of BHT, ADAEndpoints NewsKnit Health raises $11.6M for 'fundamentally different' approach to healthcare AIBioWorldArchitect Therapeutics reports new CDK2 inhibitorsBioWorldZhongshan Institute for Drug Discovery synthesizes YAP1/TEAD interaction inhibitorsBioWorldFirst cruise ship hantavirus genome points to zoonotic spilloverBioWorldCuracle, Memento ink $1B deal for ocular TIE2/VEGF bispecific

Archive

Latest Oldest
Total 10856
Page 407 / 604
Query --